von Willebrand factor and coronary heart disease: prospective study and meta-analysis

P H Whincup1, J Danesh, M Walker

  • 1Department of Public Health Sciences, St George's Hospital Medical School, London, UK.

European Heart Journal
|November 7, 2002
PubMed

Insights

Higher circulating von Willebrand factor concentrations are linked to increased coronary heart disease risk in men. Further research is needed to confirm if this association is causal.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Epidemiology

Background:

  • von Willebrand factor (vWF) is crucial for hemostasis.
  • Elevated vWF levels have been implicated in thrombotic disorders.
  • Its role in coronary heart disease (CHD) risk in the general population requires further elucidation.

Purpose of the Study:

  • To prospectively investigate the association between circulating von Willebrand factor concentrations and the risk of developing coronary heart disease.
  • To contextualize findings through a meta-analysis of existing population-based prospective studies.

Main Methods:

  • A nested case-control study within a prospective cohort of 5661 men aged 40-59 years.
  • Measurement of baseline von Willebrand factor in serum samples from 625 CHD cases and 1266 controls.
  • Statistical analysis including adjustments for age, town, and cardiovascular risk factors, alongside a meta-analysis.

Main Results:

  • Men in the highest tertile of vWF had a significantly higher odds ratio (1.83) for CHD compared to the lowest tertile, even after risk factor adjustment.
  • The association remained significant when excluding individuals with pre-existing CHD at baseline.
  • A meta-analysis of relevant studies yielded a combined odds ratio of 1.5 for CHD risk associated with elevated vWF.

Conclusions:

  • Circulating von Willebrand factor concentrations show a prospective association with incident coronary heart disease.
  • The findings suggest vWF may be a significant risk marker for CHD.
  • Further investigation is warranted to determine the causal role of vWF in the pathogenesis of coronary heart disease.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500